Skip to content      
 
 
 
 
 

Pharmaceuticals Pricing Board
Legislation

Health Insurance Act (1224/2004)

Government Decree on the Pharmaceuticals Pricing Board (196/2009) (pdf,13kB) 

Government Decree on the diseases regarded as severe and chronic on medical grounds, and the medicinal costs for which a 72 or 100 per cent reimbursement is made under chapter 5, section 5(2) of the Health Insurance Act (198/2009) (pdf ,18 kB)
Government Decree on Amendment of section 2 of the Government Decree on the diseases regarded as severe and chronic on medical grounds, and the medicinal costs for which a 72 or 100 per cent reimbursement is made under chapter 5, section 5(2) of the´Health Insurance Act (962/2011) (pdf, 7 kB)

Decree of the Ministry of Social Affairs and Health on applications and price notifications made to the Pharmaceuticals Pricing Board (201/2009) (pdf, 40 kB) 
Guidelines for preparing a health economic evaluation, attached to the Degree 201/2009) (pdf, 19 kB)

Decree of the Ministry of Social Affairs and Health on the priced services of the Pharmaceuticals Pricing Board (1233/2010) (pdf, 13 kB)

Decree by the Ministry of Social Affairs and Health on reimbursement for the non-prescription medicinal products considered necessary on medical grounds as defined in Chapter 5, Section 1, Subsection 2 of the Health Insurance Act (216/2005) (pdf, 32kB)

Government decree on medicinal products with reimbursement status granted on special grounds and diseases regarded as severe on medical grounds (616/2005) (pdf, 19kB)

Government decree on diseases regarded as severe on medical grounds for which a 72 or 42 per cent reimbursement of the costs of clinical nutritional preparations used for their treatment is made under the Health Insurance Act (197/2009) (pdf, 15kB)

Decision of the Pharmaceuticals Pricing Board authorizing the Director of the Board to decide on matters concerning the reference price system and the reimbursement status and price of a medicinal product (pdf, 36kB)

22.12.2011